Browsing: Spotlight

In 2006, in Yorkshire, England, Michael Gould, Guy Haddleton, and Sue Haddleton studied the enterprise and saw something fragile. Finance…

In 2022, when crypto felt like a heavyweight fight in the late rounds, Kathryn “Katie” Haun stepped forward with $1.5B…

Immigration is paperwork until it is personal. Then it is oxygen. In October 2023, Alma Immigration entered the market with…

There are venture firms that follow momentum, and then there are venture firms that engineer it. Costanoa Ventures belongs to…

Adverum Biotechnologies is not a lab experiment chasing headlines. It is a clinical-stage gene therapy company that has spent years…

In 2004, Jean-François Clavier planted a flag in Silicon Valley with a clear premise: the earliest checks, written with conviction,…

Copenhagen does not posture. It produces. In 2017, inside the labs of Rigshospitalet and the University of Copenhagen, Niels Behrendt,…

ARCH Venture Partners does not chase noise. ARCH Venture Partners chases signal, the kind buried in peer-reviewed journals and debated…

ADC Therapeutics does not operate in theory. It operates in consequence. Born in 2011 and shaped in 2012 under the…

Foresite Capital does not chase noise. Foresite Capital studies signal. In a market crowded with capital tourists, this firm moves…